2011 References Krummenacher I Cavassini M Bugnon O Schneider M 2011 An

2011 references krummenacher i cavassini m bugnon o

  • Walden University
  • NURS 6521N
  • Assignment
  • beckycole1975
  • 7
  • 100% (2) 2 out of 2 people found this document helpful

This preview shows page 5 - 7 out of 7 pages.

treatment failures (Krummenacher et al., 2011). References Krummenacher, I., Cavassini, M., Bugnon, O., & Schneider, M. (2011). An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care, 23 (5), 550-561. doi:10.1080/09540121.2010.525613 World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach . Geneva: World Health Organization.
Image of page 5
Response # 2 Joseph, I enjoyed your discussion post and agree with your adherence strategies of counseling and patient education. The World Health Organization (2013) also recommends using mobile phone messaging as a strategy to promote medication adherence. Reminder devices such as calendars, alarms, and pagers are tools that support an increase in viral suppression through medication adherence (WHO, 2013). Supportive interventions are also necessary to help patients to keep taking their medications. Nutritional and financial support programs help reduce the cost of care for HIV infected individuals (WHO, 2013). Medications, provider services, and testing are expensive, and many low-income individuals may have problems obtaining care and services due to financial limitations or lack of insurance. Prevention and transmission of HIV is the goal of HIV education. Pre-exposure prophylaxis (PrEP) has been shown in clinical trials to be highly effective in limiting the transmission of HIV due to any modes such as sexual transmission or injectable drug use (Worley, 2018). PrEP, when taken correctly, reduces the risk of HIV infection by 92% (Worley, 2018). Studies are being conduction in administering PrEP during pregnancy to at risk women to prevent HIV transmission to the baby (Worley, 2018). Since approximately 15% of people are unaware that they are infected, PrEP can be a useful tool to prevent the spread of transmission to unaffected individuals (Worley, 2018). References World Health Organization (2013). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach . Geneva: World Health Organization.
Image of page 6
Worley S. L. (2018). Despite gains, the war on HIV is far from over: With no cure in sight, experts urge early diagnosis and prompt treatment with better adherence. P & T: A Peer- Reviewed Journal for Formulary Management , 43 (1), 40-57. Retrieved from
Image of page 7

You've reached the end of your free preview.

Want to read all 7 pages?

  • Summer '15

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture